Sort
1,049,261 grants matching “t cell”
Transformative research on the normal and Alzheimer's disease brain through studies of neuronal gene recombination
$2,449,857Jerold Chun · Sanford Burnham Prebys Medical Discovery Institute · R56 · FY2019 · AG
Microbicide Development Program (MDP)
$2,449,845Peter A Anton · University Of California Los Angeles · U19 · FY2006 · AI
Variation in M. tuberculosis in response to host selection
$2,449,750Sarah M Fortune · Harvard School Of Public Health · DP2 · FY2007 · OD
Intervention effects of intensity and delivery style for toddlers with ASD
$2,449,732Sally J Rogers · University Of California At Davis · R01 · FY2017 · MH
Alzheimer's Disease-Related Dementia Models by Precision Editing and Relevant Genetic x Environmental Exposures
$2,449,628Catherine Cook Kaczorowski · Jackson Laboratory · R61 · FY2019 · NS
Microbes, Diet, and Hominin Evolution: Comparative and Metagenomic Approaches
$2,449,417Rebecca M Stumpf · University Of Illinois At Urbana-Champaign · · FY2009 · SBE
Immunotoxin Therapy of Solid and Hematopoietic Tumors: Preclinical Studies
$2,449,375Ira Pastan · Division Of Basic Sciences - Nci · ZIA · FY2015 · CA
SPORE IN BREAST CANCER
$2,449,341Baylor College Of Medicine · P50 · FY2001 · CA
CANCER CENTER SUPPORT
$2,449,282University Of Wisconsin Madison · P30 · FY2000 · CA
Pathogenesis, and Outcome of Autoinflammatory Diseases, NOMID/CAPS, DIRA, CANDLE, SAVI, NLRC4-MAS, Stills-like Diseases, and other Undifferentiated Autoinflammatory Diseases
$2,449,242Raphaela Goldbach-Mansky · National Institute Of Allergy And Infectious Diseases · ZIA · FY2019 · AI
Mitochondrial Energetics, Circuits and Cognitive Decline in the Aging Human Brain
$2,449,033Martin Picard · Columbia University Health Sciences · RF1 · FY2022 · AG
Regulatory Networks in Cancer Initiation and Progression
$2,448,852Douglas A Lauffenburger · Massachusetts Institute Of Technology · U54 · FY2006 · CA
Hematopoiesis in cardiovascular disease
$2,448,526Matthias Nahrendorf · Massachusetts General Hospital · P01 · FY2020 · HL
Characterization of the cellular and molecular bases of combined immunodeficiencies
$2,448,355Luigi Notarangelo · National Institute Of Allergy And Infectious Diseases · ZIA · FY2018 · AI
NCATS-DPI-22-0101 - CREATION OF AN OPEN-SOURCE PROCESS TO MANUFACTURE AAV VECTOR-BASED GENE THERAPY CANDIDATES FOR NON-COMMERCIAL CLINICAL STUDIES
$2,448,234Venkata Mangalampalli · Leidos Biomedical Research, Inc. · N01 · FY2024 · CA
Targeted Therapies in Melanoma
$2,448,186Meenhard Herlyn · Wistar Institute · P01 · FY2022 · CA
Chemical Mediators of Acute Pulmonary Disorders
$2,448,146Joshua A Boyce · Brigham And Women'S Hospital · P01 · FY2009 · HL
PROTON RADIATION THERAPY RESEARCH
$2,448,115Thomas F Delaney · Massachusetts General Hospital · P01 · FY2010 · CA
Molecular Regulation of Stem Cell Aging
$2,448,111Thomas A Rando · University Of California Los Angeles · P01 · FY2025 · AG
Single Cell Transcriptomic and Epigenomic Dissection of Opioid and Cocaine Responses in HIV
$2,447,914Manolis Kellis · Broad Institute, Inc. · U01 · FY2022 · DA
Allergic sensitization through the airway
$2,447,911Donald N Cook · National Institute Of Environmental Health Sciences · ZIA · FY2017 · ES
Sarcoidosis and A1AT Genomics & Informatics Center
$2,447,769Stephen R Wisniewski · University Of Pittsburgh At Pittsburgh · U01 · FY2015 · HL
Broad Institute Mendelian Genomic Research Center
$2,447,762Anne O'Donnell-Luria · Broad Institute, Inc. · U01 · FY2024 · HG
DF/HCC Renal Cancer SPORE
$2,447,662Beth Israel Deaconess Medical Center · P50 · FY2004 · CA
MEASUREMENT OF BIOSPECIMENS IN THE FOLIC ACID AND ZINC SUPPLEMENTATION TRIAL (FAZST) AND THE IMPAC OF DIET, EXERCISE AND LIFESTYLE (IDEAL) STUDIES
$2,447,645Michael Tsai · University Of Minnesota · N01 · FY2018 · HD